Pages Menu
Categories Menu

Posted by on Jun 27, 2014 in Foundation NewsLine |

NIH Cyclodextrin and HDAC Inhibitor Updates

Dear NNPDF Families and Friends,

The NNPDF central offices received an update from Dr. Forbes D. Porter to share with the community in regards to recent developments in both the Cyclodextrin and new Histone Deacetylase Inhibitors (HDACi) clinical trials.

Visit the Cyclodextrin Page:

Visit the HDACi Page: